Evidence map›Paper›PMID 32871747›Full record

ReviewIn vivo (Athens, Greece)

Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor.

Zoi Evangelou, Athina Zarachi, Jean Marc Dumollard, Michel Peoc'h, Ioannis Komnos, Ioannis Kastanioudakis, Georgia Karpathiou

Abstract readReview
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. CDC7 Expression in Selected Odontogenic Tumors.International journal of dentistry · 2022
    Article
  16. Left-sided facial mass in an adult female.Radiology case reports · 2021
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zoi EvangelouDepartment of Pathology and Otorhinolaryngology, University Hospital of Ioannina, Ioannina, Greece.
Athina ZarachiDepartment of Head and Neck Surgery, University Hospital of Ioannina, Ioannina, Greece.
Jean Marc DumollardDepartment of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France.
Michel Peoc'hDepartment of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France.
Ioannis KomnosDepartment of Head and Neck Surgery, University Hospital of Ioannina, Ioannina, Greece.
Ioannis KastanioudakisDepartment of Head and Neck Surgery, University Hospital of Ioannina, Ioannina, Greece.
Georgia KarpathiouDepartment of Pathology and Otorhinolaryngology, University Hospital of Ioannina, Ioannina, Greece gakarpath@yahoo.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis of odontogenic tumors can be challenging due to their rarity and diverse morphology, but when arising near the tooth, the diagnosis could be suspected. When their location is not typical, like inside the paranasal sinuses, the diagnosis is less easy. Maxillary ameloblastomas are exceedingly rare with only sparse information on their epidemiological, histological and genetic characteristics. The aim of this report is to thoroughly review the available literature in order to present the characteristics of this tumor. According to available data, maxillary ameloblastomas can occur in all ages but later than mandible ones, and everywhere within the maxillary region without necessarily having direct contact with the teeth. No sex preference has been shown. The most common histological patterns seen in this location are the follicular and plexiform ones. Maxillary ameloblastomas are locally aggressive neoplasms, thus therapy aims for excision including normal bone beyond the lesion. In contrast to mandible ameloblastomas, maxillary ones most commonly show mutations of the SMO gene. Furthermore, differential tumor diagnosis is thoroughly discussed in the present review.

Indexed as

AmeloblastomaHumansMaxillaPrognosisadamantinomahead and necknasal polypOdontogenic tumorrare tumorreviewsinonasal tumor

Identifiers

PMID32871747
PMCPMC7652510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.